García Ruiz R, Mateu Puchades A, Alegre de Miquel V
Hospital Universitario Dr. Peset, Valencia, Spain.
Hospital Universitario Dr. Peset, Valencia, Spain.
Actas Dermosifiliogr. 2024 Nov-Dec;115(10):T943-T947. doi: 10.1016/j.ad.2024.09.010. Epub 2024 Sep 12.
There is a need for epidemiological and incidence data on the occurrence of basal cell carcinoma (BCC) in Spain.
Our study was designed to retrospectively retrieve cases from our computer databases from 2010 through 2016 to provide updated data on the actual incidence of BCC in Valencia, eastern Spain.
This was an epidemiological study on basal cell carcinoma conducted in Valencia, eastern Spain. We analyzed a total of 2171 patients and 4047 tumors, and gathered data to estimate the actual incidence of BBC in our region.
Our study confirmed that the incidence of BCC is much higher than previously reported. We calculated a crude incidence of 410.38 BCCs/100 000 person-years, an adjusted rate for the European population of 256.98 BCCs/100 000 person-years, and an adjusted rate for the world population of 196.26 BCCs/100 000 person-years. Risk is up to 29.49% higher for men (464.07 cases/100 000 person-years vs 358.40 cases/100 000 person-years for women). Incidence also increases by an annual 3.91% (a significantly higher annual incidence of 8.28% in women vs a 0.92% annual incidence in men). Overall, the lifetime risk for developing a BCC is 5.8% (5.02% in women and 7% in men).
西班牙需要有关基底细胞癌（BCC）发病情况的流行病学和发病率数据。
我们的研究旨在回顾性检索2010年至2016年计算机数据库中的病例，以提供西班牙东部巴伦西亚BCC实际发病率的最新数据。
这是一项在西班牙东部巴伦西亚进行的关于基底细胞癌的流行病学研究。我们共分析了2171例患者和4047个肿瘤，并收集数据以估计我们地区BBC的实际发病率。
我们的研究证实，BCC的发病率远高于先前报道。我们计算出的粗发病率为每10万人年410.38例BCC，欧洲人群调整发病率为每10万人年256.98例BCC，世界人群调整发病率为每10万人年196.26例BCC。男性的风险高出多达29.49%（每10万人年464.07例，女性为每10万人年358.40例）。发病率每年还以3.91%的速度增长（女性年发病率显著更高，为8.28%，男性为0.92%）。总体而言，患BCC的终生风险为5.8%（女性为5.02%，男性为7%）。
